Literature DB >> 3894432

Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.

F Cassani, F B Bianchi, M Lenzi, U Volta, E Pisi.   

Abstract

Two immunofluorescence procedures to evaluate antinuclear antibodies were compared in a series of 221 patients with chronic liver disorders of various aetiologies. The use of HEp-2 cells allowed us to discriminate with more confidence between the homogeneous and speckled patterns, to show the presence of associated patterns in the same serum, and, above all, to identify two specificities, unrecognizable on tissue sections. The anticentromere antibody was found in 10% of cases of primary biliary cirrhosis and occasionally in other conditions; the antibody staining multiple nuclear dots was strictly confined to primary biliary cirrhosis (17%). With the exception of autoimmune chronic active hepatitis the prevalence of antinuclear antibodies increased in all groups, particularly in primary biliary cirrhosis. Homogeneous antinuclear antibody was associated by both immunofluorescence procedures with autoimmune chronic active hepatitis. The multiple nuclear dot antinuclear antibody turned out to be an additional marker of primary biliary cirrhosis, helpful for the positive diagnosis of primary biliary cirrhosis in a proportion of cases negative for antimitochondrial antibody. Absorption experiments showed that multiple nuclear dot and antimitochondrial antibody are antigenically distinct. Moreover, multiple nuclear dot antinuclear antibody was associated with the finding of a dry Schirmer's test.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894432      PMCID: PMC499307          DOI: 10.1136/jcp.38.7.801

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Antinuclear antibodies in primary biliary cirrhosis.

Authors:  F Powell; A L Schroeter; E R Dickson
Journal:  Lancet       Date:  1984-02-04       Impact factor: 79.321

3.  Clinical significance of mitochondrial antibodies in relation to liver disease.

Authors:  P A Berg; J C Homberg; G F Bottazzo; D Doniach
Journal:  Lancet       Date:  1981-10-10       Impact factor: 79.321

4.  Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease.

Authors:  O Epstein; H C Thomas; S Sherlock
Journal:  Lancet       Date:  1980-05-31       Impact factor: 79.321

5.  [Chronic active hepatitis with antibodies against liver and kidney microsomes].

Authors:  U Volta; G Ballardini; F Cassani; D Zauli; F B Bianchi; E Pisi
Journal:  Med Chir Dig       Date:  1980

6.  Anticentromere antibody in primary biliary cirrhosis.

Authors:  R M Bernstein; M E Callender; J M Neuberger; G R Hughes; R Williams
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

7.  Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome.

Authors:  T J Sayers; T Binder; P A Berg
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

8.  Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease.

Authors:  P Kurki; M Gripenberg; A M Teppo; M Salaspuro
Journal:  Liver       Date:  1984-04

9.  Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.

Authors:  R M Bernstein; J M Neuberger; C C Bunn; M E Callender; G R Hughes; R Williams
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  NIH conference: Primary biliary cirrhosis: a model autoimmune disease.

Authors:  S P James; J H Hoofnagle; W Strober; E A Jones
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

View more
  19 in total

1.  Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.

Authors:  Paola Loria; Amedeo Lonardo; Francesca Leonardi; Cristina Fontana; Lucia Carulli; Anna Maria Verrone; Andrea Borsatti; Marco Bertolotti; Fabio Cassani; Alberto Bagni; Paolo Muratori; Dorval Ganazzi; Francesco B Bianchi; Nicola Carulli
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.

Authors:  E I Rigopoulou; E T Davies; A Pares; K Zachou; C Liaskos; D-P Bogdanos; J Rodes; G N Dalekos; D Vergani
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

3.  Serum non-organ specific autoantibodies in human immunodeficiency virus 1 infection.

Authors:  F Cassani; L Baffoni; E Raise; L Selleri; M Monti; L Bonazzi; F M Gritti; F B Bianchi
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

4.  Diagnostic criteria of autoimmune chronic liver disease.

Authors:  F Cassani; M Fusconi; L Baffoni; U Volta; M Lenzi; F B Bianchi; E Pisi
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

5.  Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies.

Authors:  F Cassani; M Fusconi; F B Bianchi; L Selleri; L Baffoni; M Lenzi; E Pisi
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

6.  Genetic distinctions between autoimmune hepatitis in Italy and North America.

Authors:  Paolo Muratori; Albert-J Czaja; Luigi Muratori; Georgios Pappas; Silvana Maccariello; Fabio Cassani; Alessandro Granito; Rodolfo Ferrari; Vilma Mantovani; Marco Lenzi; Francesco-B Bianchi
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

7.  Specificity of antinuclear antibodies in primary biliary cirrhosis.

Authors:  M J Chou; S L Lee; T Y Chen; G J Tsay
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

8.  Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.

Authors:  F Cassani; L Muratori; P Manotti; M Lenzi; M Fusconi; G Ballardini; L Selleri; U Volta; D Zauli; R Miniero
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

9.  Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience.

Authors:  F B Bianchi; F Cassani; M Lenzi; G Ballardini; L Muratori; F Giostra; D Zauli
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

10.  Clinical correlation of anticentromere antibodies.

Authors:  M Zuber; R Gotzen; I Filler
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.